Bioactivity:

CG-400549 is an enoyl-(acyl-carrier-protein) reductase fall inhibitor potentially for the treatment of complicated acute. CG400549 had a MIC(90) of 0.5 microg/ml for Staphylococcus aureus strains and was more potent than either linezolid or vancomycin. Am

CAS nr:

934628-27-0

Purity:

98%

Molecular Weight:

340,44

SMILES:

O=C1C=C(OCCC2=CC=CS2)C=CN1CC3=CC=CC(N)=C3C

Formula:

C19H20N2O2S

Pathway:

Microbiology/Virology

Target:

Antibacterial